Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up
•This clinical practice guideline provides key recommendations on the management of gastrointestinal stromal tumours.•Recommendations have been agreed following a consensus meeting of representatives from ESMO, EURACAN and GENTURIS.•Authorship includes a multidisciplinary group of experts from sever...
Gespeichert in:
Veröffentlicht in: | Annals of oncology 2022-01, Vol.33 (1), p.20-33 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | •This clinical practice guideline provides key recommendations on the management of gastrointestinal stromal tumours.•Recommendations have been agreed following a consensus meeting of representatives from ESMO, EURACAN and GENTURIS.•Authorship includes a multidisciplinary group of experts from several European institutions, India and Japan.•ESCAT scores are given for genomic alterations with actionable drug matches. |
---|---|
ISSN: | 0923-7534 1569-8041 |
DOI: | 10.1016/j.annonc.2021.09.005 |